Form 4: Labcorp Executive Exercises RSUs, Sells Shares for Tax

Labcorp's EVP, President of Central Labs & International, Megan D. Bailey, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

Summary

• Megan D. Bailey, EVP, Pres, Central Labs & Intl at Labcorp Holdings Inc., reported transactions on February 11, 2026.
• Exercised 403 Restricted Stock Units (RSUs) into Common Stock.
• Sold 138 shares of Common Stock at $289.89 per share to satisfy tax withholding obligations.
• Following these transactions, Ms. Bailey directly owns 4,148 shares of Common Stock.
• Ms. Bailey holds 2,827 Restricted Stock Units after the reported transactions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine insider transaction involving the vesting and exercise of equity compensation, with a portion sold to cover tax liabilities, which is a standard practice and generally neutral for company sentiment.

Positives

• An executive exercised 403 Restricted Stock Units, indicating the vesting of previously granted equity compensation.

Negatives

• 138 shares of Common Stock were sold at $289.89 per share to cover tax withholding obligations related to the RSU exercise.

Future Outlook

Restricted Stock Units held by the reporting person are part of a grant that vests in three equal annual installments beginning on February 11, 2026.

Industry Context

StockSavvy.ai notes that insider transactions, particularly RSU exercises followed by tax-related sales, are routine events for executives receiving equity compensation and generally do not signal a change in company fundamentals or executive sentiment.

Stakeholder Impact

• Shareholders: Minor dilution from RSU conversion, but the tax-related sale is a common event. No significant impact on company strategy or financial health.
• Executive: Increased direct ownership of common stock after tax withholding, aligning interests with shareholders.

Next Steps

• Remaining Restricted Stock Units will continue to vest in equal annual installments starting February 11, 2026.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction involving the exercise of Restricted Stock Units and a subsequent sale of shares to cover tax obligations. It does not provide new material information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation.

Keywords

Labcorp, LH, insider transaction, Form 4, RSU, stock sale, executive compensation